SBIR/STTR Research Award
COMPUTER ASSISTED PROTEIN DESIGN
Award amount
$500,000Program and phase
SBIR · Phase IIAward year
1986Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Biosym Technologies Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
THE LONG-TERM OBJECTIVE OF THIS PROPOSAL IS TO DEVELOP AND IMPLEMENT STATE-OF-THE-ART COMPUTER SIMULATION SOFTWARE TECHNIQUES INCLUDING MOLECULAR DYNAMICS, MOLECULAR MECHANICS, NORMAL MODE ANALYSIS, AND INTERACTIVE GRAPHICS ANALYSIS INTO AN INTEGRATED SYSTEM TO ATTACK PROBLEMS IN PROTEIN DESIGN. THE ABILITY TO UNDERSTAND, GUIDE, AND ACCURATELY SIMULATE THE EFFECTS OF MODERN RECOMBINANT DNA TECHNIQUES APPLIED TO THE ENGINEERING OF PROTEINS REPRESENTS A SIGNIFICANT CONTRIBUTION TO PROTEIN ENGINEERING TECHNOLOGY. TO THIS END, PHASE I OBJECTIVES ARE TO 1. FURTHER DEVELOP AND IMPLEMENT EXISTING MOLECULAR MECHANICS/DYNAMICS PACKAGE ON THE STAR ST-100, A POWERFUL NEW GENERATION 2. DEVELOP NEW DATA ANALYSIS AND SIMULATION ALGORITHMS TO ADDRESS SPECIFIC PROTEIN DESIGN NEEDS, AND 3. CONDUCT A PRELIMINARY STUDY OF STRUCTURAL AND ENERGETIC CONSEQUENCES OF MUTAGENESIS EXPERIMENTS CARRIED OUT ON TRYPSIN IN THE LABORATORY OF PROFESSOR R. FLETTERICK, IN ORDER TO TEST AND REFINE THE TECHNIQUES. SPECIFIC PHASE I GOALS ARE TO 1. ACHIEVE A 60- TO 80-FOLD SPEED ENHANCEMENT OF THE SOFTWARE RELATIVE TO A VAX 11/780, 2. COMPLETE A SOFTWARE INTERFACE BETWEEN THEORETICAL SIMULATION AND GRAPHICS PACKAGES, 3. SET UP THE TRYPSIN SYSTEM AND CALCULATE THE STRUCTURE, ENERGETICS, AND LIGAND BINDING AFFINITY FOR VARIOUS LIGANDS OF THIS PROTEIN, AND 4. COMPARE THESE PREDICTIONS TO EXPERIMENTAL RESULTS. PHASE II RESEARCH WILL INCLUDE EXTENSIVE APPLICATIONS TO EVALUATE THE STRUCTURAL, ENERGETIC AND LIGAND BINDING PROPERTIES OF SEVERAL TRYPSIN MUTANTS AS WELL AS THE DEVELOPMENT OF MORE SOPHISTICATED ANALYSIS AND SIMULATION CAPABILITIES (SUCH AS FREE ENERGY AND ENTROPY) AND THE DEVELOPMENT OF A SCIENTIST-FRIENDLY PROGRAM INTERFACE. OUR PRIMARY COMMERICAL OBJECTIVE FOR THIS RESEARCH IS TO LICENSE THESE PROVEN SOFTWARE TOOLS AND EXPERTISE TO THE CHEMICAL AND PHARMACEUTICAL INDUSTRIES.
Technology keywords
Not reported